# SOHONOS
> **NDA215559** · New Drug Application · Sponsor: IPSEN · Approved 2023-08-16
## Drug
- **FDA Application Number:** NDA215559
- **Application type:** New Drug Application
- **Brand name:** SOHONOS
- **Generic name:** PALOVAROTENE
- **Active ingredients:** PALOVAROTENE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** IPSEN
- **Manufacturer:** Ipsen Biopharmaceuticals, Inc.
- **First approval:** 2023-08-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215559)
---
*AI Analytics · CC0 1.0*